EUVIMEDEUVIMED entdecken
Multizentrische StudieQuerschnittstudieOpen Access · CC BY 4.0

Seroprevalence and silent infection rate during SARS-CoV-2 pandemic among children and adolescents in Western Pomerania: a multicenter, cross-sectional study—the COVIDKID study

Marcus Vollmer, Daniela Kuthning, Jana Gramenz, Arevik Scholz, Robin Michael, Nico Wittmann, Udo Gesser, Christian Niesytto, Antje Vogler, Vanda Tuxhorn, Ute Lenschow, Anja Lange und 4 weitere

PeerJ · 2024

DOI: 10.7717/peerj.18384 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift PeerJ, 2024. Verfasst von Marcus Vollmer und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Bioinformatics, University Medicine Greifswald, Greifswald, Germany. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Antibodies, Viral. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Medicine Greifswald, Germany, Ministry for Economics, Labour and Health Mecklenburg-Vorpommern.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Limited data on SARS-CoV-2 seroprevalence in rural areas of northern Germany necessitate comprehensive cohort studies. We aimed to evaluate the seroprevalence, silent infection (SI) rates and risk factors for infections among children and adolescents in Western Pomerania from December 2020 to August 2022.

Methods

In this cross-sectional study, serum or plasma samples from children and adolescents (6 months to 17 years) were collected during routine blood draw. SARS-CoV-2 specific antibodies (S1 and nucleocapsid) and their neutralizing capacity were analyzed using commercially available enzyme-linked immunosorbent and neutralization assays. Socio-demographic data and information about SARS-CoV-2 infection or vaccination were obtained. Multivariable logistic regression was used to identify independent risk factors for SARS-CoV-2 infections and SI.

Results

A total of 1,131 blood samples were included into the study. Overall, SARS-CoV-2 seroprevalence was 25.1%, strongly influenced by the pandemic course, predominant virus variants, age and approval of vaccination. SI rate was 5.4% (95%-CI [3.7%–6.8%]) among unvaccinated and undiagnosed children over the entire study period with highest rates among adolescents. Main risk factor despite the time at risk for silent infections was an infected household member (Odds ratio = 9.88, 95%-CI [4.23–22.9], p < 0.001). Factors associated with overall infections (known and silent) also include the infection of a household member (Odds ratio = 17.8, 95%-CI [10.7–29.6], p < 0.001).

Conclusions

We believe that the introduction of governmental measures and systematic test strategies in schools strongly impacted on the SI rate, as we suspect that asymptomatic cases have already been identified, resulting in surprisingly low SI identified in our study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2Antibodies, ViralHumansSeroepidemiologic StudiesAdolescentCross-Sectional StudiesChildMaleGermanyFemaleChild, PreschoolInfantRisk FactorsAsymptomatic InfectionsAntibodies, Neutralizing

Stichwörter der Autor:innen

Covid-19IgA-S1IgG-S1NCP-IgGPandemicPediatricSARS-CoV-2SerologySeroprevalenceSilent infection

Substanzen

Antibodies, ViralAntibodies, Neutralizing

Autor:innen und Institutionen

  • Institute of Bioinformatics, University Medicine Greifswald, Greifswald, Germany.
  • Pediatric Rheumatology, Department Pediatric and Adolescent Medicine, University Medicine Greifswald, Greifswald, Germany.
  • German Center for Child and Adolescent Health (DZKJ). Partner site Greifswald/Rostock, Greifswald, Germany.
  • Children's Hospital, Sana Hospital Rügen, Bergen, Germany.
  • Department of Pediatrics, AMEOS Hospital Anklam, Anklam, Germany.
  • Department of Pediatrics, Asklepios Clinic Pasewalk, Pasewalk, Germany.

Förderung

  • University Medicine Greifswald, Germany
  • Ministry for Economics, Labour and Health Mecklenburg-Vorpommern

Zitieren

APA

Vollmer, M., Kuthning, D., Gramenz, J., Scholz, A., Michael, R., Wittmann, N., Gesser, U., Niesytto, C., Vogler, A., Tuxhorn, V., Lenschow, U., Lange, A., Linnemann, K., Lode, H., Kaderali, L., & Meyer-Bahlburg, A. (2024). Seroprevalence and silent infection rate during SARS-CoV-2 pandemic among children and adolescents in Western Pomerania: a multicenter, cross-sectional study—the COVIDKID study. PeerJ. https://doi.org/10.7717/peerj.18384

Vancouver

Vollmer M, Kuthning D, Gramenz J, Scholz A, Michael R, Wittmann N, et al. Seroprevalence and silent infection rate during SARS-CoV-2 pandemic among children and adolescents in Western Pomerania: a multicenter, cross-sectional study—the COVIDKID study. PeerJ. 2024. doi:10.7717/peerj.18384

BibTeX
@article{Vollmer2024,
  author = {Vollmer, Marcus and Kuthning, Daniela and Gramenz, Jana and Scholz, Arevik and Michael, Robin and Wittmann, Nico and Gesser, Udo and Niesytto, Christian and Vogler, Antje and Tuxhorn, Vanda and Lenschow, Ute and Lange, Anja and Linnemann, Kristina and Lode, Holger and Kaderali, Lars and Meyer-Bahlburg, Almut},
  title = {Seroprevalence and silent infection rate during SARS-CoV-2 pandemic among children and adolescents in Western Pomerania: a multicenter, cross-sectional study—the COVIDKID study},
  journal = {PeerJ},
  year = {2024},
  doi = {10.7717/peerj.18384}
}
Kostenlos starten →